Cardiac troponins: Outcome predictors in hemodialysis patients

Journal of Artificial Organs

Volumn 12, Issue 4, 2009, Pages 258-263

  Petrović, Dejan ^a   Stojimirović, Biljana B ^b  

^a Clinic of Urology and Nephrology   (Serbia)

^b Institute of Urology and Nephrology   (Serbia)

Author keywords

Cardiac troponin I; Cardiac troponin T; Hemodialysis; Mortality

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HOMOCYSTEINE; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE; SYMPTOMATOLOGY; AGED; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; FOLLOW UP; MIDDLE AGED; PREDICTION AND FORECASTING; RENAL REPLACEMENT THERAPY; SERBIA;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; SERBIA; TROPONIN I; TROPONIN T;

EID: 77949906677     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-009-0472-5     Document Type: Article

References (37)

1. Parfrey PS. Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant 2000;15(Suppl 5):58-68
2. Meier P, Vogt P, Blanc E. Ventricular arrhythmias and sudden cardiac death in end-stage renal disease patients on chronic hemodialysis. Nephron 2001;87:199-214
3. Karnik JA, Young BS, Lew NL, Herget M, Dubinsky C, Lazarus JM, Chertow GM. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001;60:350-357
4. Herzog CA, Mangrum M, Passman R. Sudden cardiac death and dialysis patients. Semin Dial 2008;21:300-307
5. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006;48:1-11
6. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, Collins PO, Brecker SJ. Cardiac structural and functional abnormalities in end-stage renal disease patients with elevated cardiac troponin T. Heart 2006;92:804-809
7. Hussein M, Mooij J, Roujouleh H, Shenawi OA. Cardiac troponin- I and its prognostic signifi cance in a dialysis population. Hemodial Int 2004;8:332-337
8. Herzog CA. Cardiac arrest in dialysis patients: taking a small step. Semin Dial 2004;17:184-185
9. Herzog CA. Sudden cardiac death and acute myocardial infarction in dialysis patients: perspectives of a cardiologist. Semin Nephrol 2005;25:363-366
10. Herzog CA. Can we prevent sudden cardiac death in dialysis patients? Clin J Am Soc Nephrol 2007;2:410-412
11. Parfrey PS, Collingwood P, Foley RN, Bahrle A. Left ventricular disorders detected by M-mode echocardiography in chronic uraemia. Nephrol Dial Transplant 1996;11:1328-1331
12. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 2001;12:1079-1084
13. London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 2003;16:85-94
14. Rigatto C, Parfrey PS. Uraemic cardiomyopathy: an overload cardiomyopathy. J Clin Basic Cardiol 2001;4:93-95
15. Zoccali C, Mallamaci F, Tripepi G. Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 2004;15(Suppl 1):77-80
16. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 2006;70:26-33
17. Scott B, Deman A, Peeters P, Van den Branden C, Stolear J-C, Camp GV, Verbeelen D. Cardiac troponin T and malonaldehydemodified plasma lipids in haemodialysis patients. Nephrol Dial Transplant 2003;18:737-742
18. Boulier A, Jaussent I, Terrier N, Maurice F, Rivory J-P, Chalabi L, Boularan A-M, Delcourt C, Dupuy A-M, Canaud B, Cristol J-P. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in hemodialysis patients. Nephrol Dial Transplant 2004;19:2313-2318
19. Apple FS, Murakami MAM, Pearce LA, Herzog CA. Multibiomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004;50:2279-2285
20. Wood GNI, Keevil B, Gupta J, Foley R, Bubtana A, McDowell G, Ackrill P. Serum troponin T measurement in patients with chronic renal impairment predicts survival and vascular disease: a 2-year prospective study. Nephrol Dial Transplant 2003; 18:1610-1615
21. Herzog CA. Kidney disease in cardiology. Nephrol Dial Transplant 2007;22:43-46
22. Dierkes J, Domröse U, Westphal S, Ambrosch A, Bosselmann H-P, Neumann KH, Luley C. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000;102:1964-1975
23. Conway B, McLaughlin M, Sharpe P, Harty J. Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis. Nephrol Dial Transplant 2005;20:2759-2764
24. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-2945
25. Ooi DS, Zimmerman D, Graham J, Wells GA. Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clin Chem 2001;47:412-417
26. Troyanov S, Ly QH, Schampaert E, Ammann H, Lalumiere G, Madore F, Quérin S. Diagnostic specificity and prognostic value of cardiac troponins in asymptomatic chronic haemodialysis patients: a three-year prospective study. Heart 2005;91:1227-1228
27. Beciani M, Tedesco A, Violante A, Cipriani S, Ayyarito M, Sturniolo A, Splendiani G. Cardiac troponin I (second-generation assay) in chronic haemodialysis patients: prevalence and prognostic value. Nephrol Dial Transplant 2003;18:942-946
28. Ishii J, Nomura M, Okuma T, Minagawa T, Naruse H, Mori Y. Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis. Clin Chim Acta 2001;312:69-79
29. Iliou MC, Fumeron C, Benoit MO, Tuppin P, Calonge VM, Moatti N, Buisson C, Jacquot C. Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) Study. Am J Kidney Dis 2003;42:513-523
30. Nolan CR. Strategies for Improving Long-Term Survival in Patients with ESRD. J Am Soc Nephrol 2005;16(11 Suppl 2): 120-127
31. Petrović D, Jagić N, Miloradović V, Stojimirović B. Clinical importance of biochemical markers of cardiac damage in hemodialysis patients. Ser J Exp Clin Res 2008;9:5-8 (in Serbian)
32. Petrović D, Stojimirović B. Left ventricular hypertrophy in patients treated with regular hemodialysis. Med Rev 2008;LXI(7-8):369-374 (in Serbian)
33. Zoccali C, Tripepi G, Mallamaci F. Predictors of cardiovascular death in ESRD. Semin Nephrol 2005;25:358-362
34. McCullough PA. Coronary artery disease. Clin J Am Soc Nephrol 2007;2:611-616
35. Johnston N, Dargie H, Jardine A. Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease. Heart 2008;94(8):1080-1088
36. Herzog CA, Litrell K, Arko C. Clinical characteristics of dialysis patients with acute myocardial infraction in the United States. Circulation 2007;116(13):1465-1472
37. Herzog CA. Kidney disease in cardiology. Nephrol Dial Transplant 2008;23(1):42-46